checkAd

     223  0 Kommentare Mydecine Innovations Group Announces Filing of a Provisional Patent for Mindleap’s Mental Health Technology - Seite 2

    Included in the launch of Mindleap 2.0 is the release of new Digital Mental Health and Well-Being Programs. Each of these new programs will feature daily audio and or video sessions created by world-class experts in each of their respective fields. The updated platform will also include various audio programs ranging from psychedelic integration, addiction, meditation, breathwork, cognitive behavioral therapy and others. As development progresses further, Mindleap technologies will include advancements that will take advantage of enhanced data collection and analytics to bring forth further assistance to users including a proprietary Mindleap Well-Being Score.

    About Mindleap Health

    Mindleap Health Inc. is a virtual healthcare company that offers technology solutions that allow people to improve their mental health and wellbeing. The Mindleap platform provides remote telemedicine services for mental health coaching through its international network of mental health specialists along with mental health tracking and analytics. The Mindleap platform brings convenience, improves access to treatments and can lead to more personal breakthroughs. Mindleap’s proprietary platform is designed to provide professional support and personalized treatment for every user. The company’s mission is to upgrade mental health by simplifying, modernizing, and improving access to mental health treatments for millions of people around the world.

    Download for Android
    Download for IOS

    Watch the Mindleap Platform Overview Video

    Apply to become a Specialist on Mindleap

    Learn about Mindleap Health

    Learn about The Past and Future of Psychedelics as a Medicine

    For further information about Mydecine Innovations Group Inc., please visit the Company’s profile on SEDAR at www.sedar.com or visit the Company’s website at www.mydecine.com.

    Mydecine Innovations Group Media Contacts:
    Anne Donohoe / Nick Opich
    KCSA Strategic Communications
    adonohoe@kcsa.com / nopich@kcsa.com
    1-212-896-1265 / 1-212-896-1206

    On behalf of the Board of Directors:
    Joshua Bartch, Chief Executive Officer
    contact@mydecineinc.com

    Corp Communication:
    Charles Lee, Investor Relations
    corp@mydecineinc.com
    +1-720-277-9879

    Mindleap Health Platform Services Disclaimer: Mindleap Services are designed to connect users of our Services with mental health specialists so as to receive assistance and guidance with integrating their prior psychedelic or consciousness-expanding experiences and translating them into positive changes. Our Services are not designed or intended for the integration or translation of a presently occurring psychedelic experience and must not be used for that purpose. Psychedelic substances are legally controlled or prohibited in many jurisdictions, but there are legal means to have a psychedelic or conscious-expanding experience in certain circumstances. You are solely responsible and liable for adequately informing yourself of the Laws of your jurisdiction before using our Services and determining if use of our Services and the receipt of Specialist Services (defined below) is lawful in your jurisdiction. Our Services are meant to be used exclusively in connection with lawful activities and must not be used in connection with illegal substances or illegal activities. Without limiting the previous sentence, you are not permitted to promote, procure, consume, or sell illegal substances through the Services. Do not use psychedelic substances if doing so is unlawful in your jurisdiction. Possession of psychedelic substances in violation of applicable laws can carry significant penalties, including years of incarceration.

    Seite 2 von 4



    globenewswire
    0 Follower
    Autor folgen

    Weitere Artikel des Autors


    Verfasst von globenewswire
    Mydecine Innovations Group Announces Filing of a Provisional Patent for Mindleap’s Mental Health Technology - Seite 2 Digital health platform will combine telemedicine, on-demand mental health programs and advanced wellbeing analyticsDENVER, Feb. 17, 2021 (GLOBE NEWSWIRE) - Mydecine Innovations Group, Inc., (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) ("Mydecine" or the …

    Schreibe Deinen Kommentar

    Disclaimer